AzTrials
AzTrials

DepressionNCT02748187

Attachment Style and Reflective Functioning in CBASP

A study testing CBASP in people with Depression, run by University of Edinburgh at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cognitive behavioural analysis system of psychotherapy (CBASP) is one of the only psychological models and treatments that has been designed specifically for patients diagnosed with chronic depression. CBASP in combination with antidepressants has been found to be the most effective treatment for chronic depression. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Depression
What is being tested?
CBASP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteUnited Kingdom
Study dates
Jan 2016to Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Clients will be included in this study if they meet the following criteria:
  • Meet Diagnostic Statistical Manual-5 (DSM-5) criteria for persistent depressive disorder
  • Have the capacity to provide informed consent
  • Are aged 18 - 64 inclusive
  • Speak fluent English
  • Do not meet any of the exclusion criteria
Show all 9Show fewer
  • Therapists will be included in the study if they meet the following criteria:
  • Have received training in CBASP
  • Have a qualification in at least one psychological therapy

Who cannot join

  • Clients will be excluded from the study if they do not meet inclusion criteria, as well as fulfilling any of the following criteria:
  • Current significant substance misuse
  • Undergoing other psychological treatment
  • Presence of learning disability or significant cognitive impairment
  • Presence of psychosis
  • Therapists will be excluded from the study if they do not meet the inclusion criteria.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Sarah Buckley

    Edinburgh, Midlothian

Other trials in United Kingdom

About this study

Official title: Are Therapist and Client Attachment Style and Reflective Functioning Associated With Outcomes in Cognitive Behavioural Analysis System of Psychotherapy (CBASP): A Longitudinal Proof of Concept Study

Cognitive behavioural analysis system of psychotherapy (CBASP) is one of the only psychological models and treatments that has been designed specifically for patients diagnosed with chronic depression. CBASP in combination with antidepressants has been found to be the most effective treatment for chronic depression. Despite an increasing amount of research into this intervention, researchers are less aware of the role that specific and common ingredients are accounted for in outcomes. Given that CBASP is a treatment model endorsed by the National Health Service Scotland (NHS Scotland), gaining a deeper knowledge and understanding about the active ingredients involved in their success ensures current practice is embedded in an evidence base. Conducting this research adds to the gap in the literature and identifies areas in which further exploration is warranted. Given the emphasis on therapist variables in relation to treatment outcomes, the results of this research will have wider implications from a service resource perspective. Training may be altered or needs emphasised in line with the results of the study to ensure most efficacious outcomes.

Limited research has looked at therapist and client variables that may contribute to therapeutic alliance/engagement, and clinical outcomes. The current study proposes to explore two variables that are hypothesized to contribute to outcomes based on the theoretical framework CBASP is grounded on, namely therapist and client attachment style and reflective functioning. This will be done by providing CBASP to a small number of participants and gathering outcome data from therapists and clients at each therapy appointment. Participants will also complete the Adult Attachment Interview (AAI), a semi structured interview which can also be coded for reflective functioning. This is a proof of concept case series design that aims to provide an analysis of individual psychological change in relation to the above variables of interest.

Read the detailed description

CBASP will consist of treatment of usual (i.e. one one-hour individual sessions on a weekly basis for up to 20 weeks) with additional outcome measures to be completed at each session. Therapists will receive a research pack which will outline when, and what, measures to administer and complete. To ensure anonymity and confidentiality of data collected, participants will be given identification numbers before data is submitted to a spread sheet for analysis.

9 CBASP therapists have been identified as suitable for participation in this study. Therapists will have the option to choose whether to take part in the research. Similarly, clients will be given the choice to take part in the research. To ensure at least one set of outcomes are achieved it is an aim of the study to provide the therapist with a minimum caseload of 2.

Conditions
Depression
Being tested
CBASP
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBASPOther

    Interpersonal psychotherapy for chronic depression

Study groups in NCT02748187
Study groupRoleWhat they receive
InterventionExperimentalCognitive Behavioural Analysis System of Psychotherapy
Receives: Other: CBASP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological distress on the Clinical Outcome in Routine Evaluation Measure (CORE)

    The CORE questionnaire, administered to clients, required 10 questions in relation to current mood to be answered. A total score is provided by adding up items. This is a routine outcome measure used in CBASP.

    Measured: 5 minutes

  2. Depressive symptomology on the Patient Health Questionnaire (PHQ-9)

    The PHQ-9 is a screening tool and monitor for depression that will be administered to clients. A total score is provided by adding up items.

    Measured: 5 minutes

  3. Therapeutic relationship on the Working Alliance Inventory (WAI)

    The WAI is a questionnaire that assesses the quality of the therapeutic relationship. There are two versions, namely client and therapist versions. Both therapists and clients will complete this questionnaire. A total score is provided by adding up items.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionAug 2017
  4. Study completionAug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02748187
Sponsor's protocol ID
15/SS/0232
Status last verified
Jun 2021
First submitted
27 Mar 2016
Last updated
3 May 2024
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: via peer review journal

Publications

  • Buckley; Attachment Style and Depression: An Investigation into Interpersonal Factors and Processes; DClinPsychol dissertation, available from https://era.ed.ac.uk/bitstream/handle/1842/25759/Buckley2017.pdf?sequence=1&isAllowed=y

Questions about this trial

What is this clinical trial studying?

A study testing CBASP in people with Depression, run by University of Edinburgh at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological distress on the Clinical Outcome in Routine Evaluation Measure (CORE) (time frame: 5 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02748187, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in